• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Mood Stabilizer Plus Antidepressant May Protect Against Mania

Mood Stabilizer Plus Antidepressant May Protect Against Mania

September 1, 2014
Glen Spielmans, PhD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies ertaining to this educational activity.

Subject:
Bipolar Disorder

Short Description:

Mood Stabilizer plus Antidepressant May Protect Against Mania

Background:

Most of you would hesitate to put a patient with bipolar I on antidepressants without adding a mood stabilizer, in order to prevent a switch to mania. If this is your clinical practice, you are following the recommendations of the APA consensus guidelines for the treatment of bipolar depression. But the hard data to support the danger of switching is surprisingly weak. Clinical trials have not yielded consistent results. This is why we read with interest a recent study providing a bit more evidence that unopposed antidepressants can indeed cause manic switches—but only in bipolar I, and only over the short-term.

Researchers in Sweden used a national database to identify all patients during the period of 2005 to 2009 who had been diagnosed with bipolar disorder I and who started antidepressants. Of the 3,240 patients identified, nearly 35% were on antidepressant monotherapy while the remainder were also prescribed a mood stabilizer in addition to the antidepressant (in this study, lithium, valproate, or lamotrigine). Importantly, the researchers excluded all patients who had taken antidepressants in the previous year, to better reveal new “switching” events.

Records were reviewed for the occurrence of mania during the period after the antidepressant was started. It turns out that antidepressant monotherapy was, indeed, linked to an increased risk of mania—but only in the short term (0 to 3 months after starting the antidepressant)—the hazard ratio (HR) was 2.83, meaning that these patients were almost three times more likely to become manic than those also taking a mood stabilizer. However, 3 to 9 months after starting the medication, there was no higher prevalence of mania (HR 0.71).

When researchers focused on patients who were prescribed mood stabilizers in addition to antidepressants, there was no increased risk of mania at all, either in the 0 to 3 month period or the 3 to 9 month period. In fact, for these patients the 3 to 9 month risk of mania was actually reduced (HR 0.63).

The researchers recommend the use of mood stabilizers when antidepressants are prescribed in bipolar disorder, and also point out that more options are necessary for the management of bipolar depression. It should be noted that the present study did not evaluate whether atypical antipsychotics, commonly used in all phases of bipolar disorder, can also prevent the switch to mania (Viktorin A et al, Am J Psychiatry 2014;online ahead of print).

TCPR’s Take: The researchers recommend that clinicians add mood stabilizers to antidepressants for bipolar disorder I. This is not a huge surprise and is in line with how most of us practice. But don’t be overly seduced by these results. This was a retrospective study that relied upon diagnoses given by non-researcher clinicians, and not on standardized interviews. Furthermore, it was limited by a non-standardized definition of “mania,” and it did not evaluate patients with bipolar II disorder. The best we can say is that at least these results don’t contradict standard practice.

General Psychiatry
KEYWORDS bipolar_disorder mood_stabilizers research_updates
Ccpr octnovdec2020 qa1 headshot spielmans 150x150
Glen Spielmans, PhD

Two New Meta-Analyses Compare Antidepressants

More from this author
www.thecarlatreport.com
Issue Date: September 1, 2014
SUBSCRIBE NOW
Table Of Contents
Step Right Up—Meaningful Use Incentives are Adding Up
Op-Ed: Maintenance of Certification—Is it safe to opt out?
Maintenance of Certification: What You Need to Know
Using Transcranial Magnetic Stimulation (TMS) in Your Practice
Mood Stabilizer Plus Antidepressant May Protect Against Mania
CBT Moderately Effective in Improving Quality of Life for Anxiety Disorders
Another Sleeping Pill on the Market: Merck’s Belsomra
Should We Share Therapy Notes with Our Patients?
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.